Skip to content

Insider · CIK 0001818070

Diana Brainard

ceoofficerdirector

Files at NKTR (NEKTAR THERAPEUTICS), KLRS (Kalaris Therapeutics, Inc.). First filing Oct 23, 2024, latest Nov 20, 2024.

Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 3
$0 bought, $22k sold

Where the trades landed

Last year at the company this insider has traded most, with each buy and sell on the bar it happened.

KLRS: Kalaris Therapeutics, Inc.

KLRSOct 9, 2026 · close 2.36

Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™

Signals

This insider’s open-market buys and sells, scored.

ScoreCompanyValueHoldingsPrice contextFiled
40Moderate
KLRSsell 4
Kalaris Therapeutics, Inc.
$4,775
8,706 shares
-1%-
40Moderate
KLRSsell 4
Kalaris Therapeutics, Inc.
$9,176
10,609 shares
-1%-
40Moderate
KLRSsell 4
Kalaris Therapeutics, Inc.
$7,597
9,752 shares
-1%-

Transactions

Every row this insider has filed, newest first.

DateCompanyTransactionSharesPriceValueHoldings afterFiled
Sep 23, 2026NKTR
NEKTAR THERAPEUTICS
AGrant or award
Common Stock
+2,000$0.00$03,90417 d ago
Sep 23, 2026NKTR
NEKTAR THERAPEUTICS
AGrant or award
Stock Optionderivative
+4,000$0.00$04,00017 d ago
Nov 19, 2024KLRS
Kalaris Therapeutics, Inc.
SOpen-market sale
Common Stock
-8,706$0.55$4,775723,363Nov 20, 2024
Nov 5, 2024KLRS
Kalaris Therapeutics, Inc.
SOpen-market sale
Common Stock
-10,609$0.86$9,176732,069Nov 6, 2024
Oct 21, 2024KLRS
Kalaris Therapeutics, Inc.
SOpen-market sale
Common Stock
-9,752$0.78$7,597742,678Oct 23, 2024

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.

Diana Brainard: insider trades and track record | InsiderTell